MR moderate or greater in severity and severe MR detected with high areas under the curve
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
MACE, heart failure composite end point, cardiovascular death, and all-cause death all improved with semaglutide for patients with versus without heart failure